Clik here to view.
Novocure touts data from Optune-paclitaxel combination study
By Sarah Faulkner NovoCure (NSDQ:NVCR) announced yesterday that its ‘tumor treating fields, combined with the drug paclitaxel, are effective against ovarian cancer, the 5th most-common cause of cancer...
View ArticleClik here to view.
Judge fast-tracks Alere suit against Abbott, urges mediation
A Delaware judge today expedited Alere‘s (NYSE:ALR) lawsuit against Abbott (NYSE:ABT) seeking to force Abbott to adhere to the terms of its $5.8 billion acquisition, but urged the companies to reach an...
View ArticleClik here to view.
Stryker, Monsanto director Parfet steps down | Personnel Moves, Sept. 2, 2016
Stryker, Monsanto director Parfet steps down Stryker (NYSE:SYK) and Monsanto (NYSE:MON) said this week that board member William Parfet stepped down from their boards, but declined to reveal the reason...
View ArticleClik here to view.
FDA approves Concentric Medical’s Trevo clot retrievers
The FDA said today it granted expanded approval to 2 Stryker (NYSE:SYK) subsidiary Concentric Medical‘s Trevo clot retrieval devices, with new indications as initial therapy for strokes due to blood...
View ArticleClik here to view.
Balt International buys Blockade Medical
European medtech firm Balt International said today it acquired endovascular device developer Blockade Medical for an undisclosed amount. The acquisition is part of Balt’s ongoing strategy to bolster...
View ArticleClik here to view.
PPC Industries sub Kelpac Medical buys Xeridiem Medical
PPC Industries’ Kelpac Medical division said today it acquired Xeridiem Medical Devices for an undisclosed amount. Get the full story at our sister site, Medical Design & Outsourcing. The post PPC...
View ArticleClik here to view.
Insulet re-ups material deal with Flextronics
Insulet (NSDQ:PODD) said yesterday it extended a materials and manufacturing deal with Flextronics (NSDQ:FLEX) to produce and manufacture its Omnipod insulin management system for an additional 5...
View ArticleClik here to view.
Stanford launches independent study of Fibralign’s BioBridge
Stanford University has begun enrollment in an investigator-led clinical study of Fibralign‘s BioBridge collagen matrix designed for treating secondary lymphedema, the company said yesterday. The...
View ArticleClik here to view.
US FDA explains its approach to “real-world” evidence and data for medical...
By Stewart Eisenhart, Emergo Group Recent guidance from US medical device market regulators explains when and how real-world data and evidence obtained via methods other than clinical trials are used...
View ArticleClik here to view.
Rox Medical raises $40m Series E for hypertension ‘stent’
Rox Medical said today that it raised a $40 million Series E round for the stent-like Coupler device it developed to treat hypertension by connecting the femoral artery and the femoral vein. The round...
View ArticleClik here to view.
Boehringer Ingelheim touts Stiolto Respimat data
Boehringer Ingelheim yesterday touted results from a Phase III trial showing that its Stiolto Respimat, a drug-device combination helps people with chronic obstructive pulmonary disease walk for longer...
View ArticleClik here to view.
Medtronic opens office in Vietnam
Medtronic (NYSE:MDT) said yesterday it opened a new office in Vietnam to greater serve the region. Fridley, Minn.-based Medtronic said it will “make important contributions” to fight cardiovascular...
View ArticleClik here to view.
Biotronik hits the market in Japan with Ilivia MRI-safe ICD
Biotronik said yesterday it launched its Ilivia magnetic resonance imaging-safe implantable cardioverter defibrillator in Japan. The Berlin-based comapny said the Ilivia device features both its ProMRI...
View ArticleClik here to view.
Edwards Lifesciences’ CardiAQ Valve wants to add $23m to Neovasc’s $70m trade...
Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies wants a federal judge in Massachusetts to add 33%, or more than $23 million, to the $70 million trade theft verdict lodged against...
View ArticleClik here to view.
FDA: No evidence of data manipulation in clinical trials for Bayer’s Essure
The FDA said it completed a review of a trade complaint which alleged that Bayer (ETR:BAYN) was engaged in clinical trial misconduct and altering data, saying it found no signs of manipulation. The...
View ArticleClik here to view.
Insulet taps ATS Automation Tooling for planned U.S. plant, beefs up...
Insulet (NSDQ:PODD) said today it inked a 5-year deal with ATS Automation Tooling Systems to construct an automated manufacturing assembly line for its products and announced a pair of new executive...
View ArticleClik here to view.
Cardinal Health to pay up to $310m for Navidea’s LymphoSeek
Navidea (NYSE:NAVB) said today it inked a letter of intent with Cardinal Health (NYSE:CAH) to sell its Lymphoseek injection for up to $310 million. The sale includes all current FDA-approved...
View ArticleClik here to view.
Tiny ‘fitbits’ to keep tabs on the body from within
(Reuters) – Scientists are developing dust-sized wireless sensors implanted inside the body to track neural activity in real-time, offering a potential new way to monitor or treat a range of conditions...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 6, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Alphatec closes $80m sale of int’l biz to Globus, announces 1-12 reverse split
Alphatec (NSDQ:ATEC) said it closed the $80 million sale of its international operations and distribution channels to Globus Medical (NYSE:GMED) and announced a 1-for-12 reverse stock split. Carlsbad,...
View Article